Found: 14
Select item for more details and to access through your institution.
The Biodistribution of the Spike Protein after Ad26.COV2.S Vaccination Is Unlikely to Play a Role in Vaccine-Induced Immune Thrombotic Thrombocytopenia.
- Published in:
- Vaccines, 2024, v. 12, n. 5, p. 559, doi. 10.3390/vaccines12050559
- By:
- Publication type:
- Article
Intravenous Administration of Ad26.COV2.S Does Not Induce Thrombocytopenia or Thrombotic Events or Affect SARS-CoV-2 Spike Protein Bioavailability in Blood Compared with Intramuscular Vaccination in Rabbits.
- Published in:
- Vaccines, 2023, v. 11, n. 12, p. 1792, doi. 10.3390/vaccines11121792
- By:
- Publication type:
- Article
Therapeutic efficacy of combined active and passive immunization in ART-suppressed, SHIV-infected rhesus macaques.
- Published in:
- Nature Communications, 2022, v. 13, n. 1, p. 1, doi. 10.1038/s41467-022-31196-5
- By:
- Publication type:
- Article
Therapeutic efficacy of an Ad26/MVA vaccine with SIV gp140 protein and vesatolimod in ART-suppressed rhesus macaques.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00477-x
- By:
- Publication type:
- Article
A homologous or variant booster vaccine after Ad26.COV2.S immunization enhances SARS-CoV-2–specific immune responses in rhesus macaques.
- Published in:
- Science Translational Medicine, 2022, v. 14, n. 638, p. 1, doi. 10.1126/scitranslmed.abm4996
- By:
- Publication type:
- Article
Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00454-4
- By:
- Publication type:
- Article
SARS-CoV-2 binding and neutralizing antibody levels after Ad26.COV2.S vaccination predict durable protection in rhesus macaques.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-26117-x
- By:
- Publication type:
- Article
Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 Spike immunogen induces potent humoral and cellular immune responses.
- Published in:
- NPJ Vaccines, 2020, v. 5, n. 1, p. N.PAG, doi. 10.1038/s41541-020-00243-x
- By:
- Publication type:
- Article
A vaccine-induced gene expression signature correlates with protection against SIV and HIV in multiple trials.
- Published in:
- Science Translational Medicine, 2019, v. 11, n. 507, p. 1, doi. 10.1126/scitranslmed.aaw4236
- By:
- Publication type:
- Article
Nasal Immunization Confers High Avidity Neutralizing Antibody Response and Immunity to Primary and Recurrent Genital Herpes in Guinea Pigs.
- Published in:
- Frontiers in Immunology, 2016, v. 7, p. 1, doi. 10.3389/fimmu.2016.00640
- By:
- Publication type:
- Article
Polyethyleneimine is a potent systemic adjuvant for glycoprotein antigens.
- Published in:
- International Immunology, 2014, v. 26, n. 10, p. 531, doi. 10.1093/intimm/dxu055
- By:
- Publication type:
- Article
Polyethyleneimine is a potent mucosal adjuvant for viral glycoprotein antigens.
- Published in:
- Nature Biotechnology, 2012, v. 30, n. 9, p. 883, doi. 10.1038/nbt.2344
- By:
- Publication type:
- Article
Mixed Adjuvant Formulations Reveal a New Combination That Elicit Antibody Response Comparable to Freund's Adjuvants.
- Published in:
- PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0035083
- By:
- Publication type:
- Article
A Novel Strategy for Inducing Enhanced Mucosal HIV-1 Antibody Responses in an Anti-Inflammatory Environment.
- Published in:
- PLoS ONE, 2011, v. 6, n. 1, p. 1, doi. 10.1371/journal.pone.0015861
- By:
- Publication type:
- Article